• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Pipeline

Pipeline

August 6, 2018
Company Drug/Device Medical Condition Status
Clover Biopharmaceuticals, Inc. SCB-808 rheumatoid arthritis (RA) and other autoimmune diseases Phase I trial initiated
Arcus Biosciences, Inc. AB154 anti-TIGIT antibody Phase I trial initiated
CeraPedics P-15L Peptide Enhanced Bone Graft transforaminal lumbar interbody fusion (TLIF) surgery Phase I trial initiated enrolling 364 subjects
BioLineRx Ltd. AGI-134 patient-specific tumor neoantigens Phase I/IIa trial initiated
Avelas BioSciences, Inc. AVB-620 primary, non-recurrent breast cancer undergoing surgery Period II, Phase II trial initiated enrolling 31 subjects
Biohaven Pharmaceutical Holding Company, Ltd. trigriluzole (BHV-4157) mild-to-moderate Alzheimer’s disease (AD) Phase II/III trial initiated enrolling 292 subjects
Kala Pharmaceuticals, Inc. KPI-121 0.25% dry eye disease Phase III trial initiated enrolling 900 subjects
GE Healthcare and Lantheus Holdings, Inc. Flurpiridax coronary artery disease Phase III trial initiated enrolling 650 subjects
Progenics Pharmaceuticals Azedra adult and pediatric subjects 12 years and older with iobenguane scan positive, unresectable, locally advanced or metastatic pheochromocytoma or paraganglioma who require systemic anticancer therapy NDA approval granted by the FDA
United Therapeutics Corporation Remodulin pulmonary arterial hypertension (PAH) NDA approval granted by the FDA
Sensus Healthcare, Inc. SRT-100+ non-melanoma skin cancer and keloids 510(k) clearance granted by the FDA
Modulated Imaging Clarifi Imaging System peripheral vascular diseases, diabetic foot ulcers, burns, skin flaps and chronic wounds 510(k) clearance granted by the FDA
Daiichi Sankyo Company, Ltd. quizartinib relapsed/refractory FLT3-ITD acute myeloid leukemia (AML) Breakthrough Therapy Designation granted by the FDA
Armagen Inc. GT-184 Mucopolysaccharidosis type IIIA (also known as Sanfilippo Syndrome A or MPS IIIA) Orphan Drug Designation granted by the FDA
Endomag Magtrace breast cancer PMA granted by the FDA
Hologic, Inc. Panther Fusion GBS assay Group B Streptococcus (GBS) Clearance granted by the FDA
Shionogi & Co., Ltd. Mulpleta (lusutrombopag) thrombocytopenia in adult patients with chronic liver disease (CLD) who are scheduled to undergo a procedure Approval granted by the FDA
Roche cobas cervical cancer Approval granted by the FDA
Indivior PLC PERSERIS schizophrenia Approval granted by the FDA

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing